Structural and functional studies of complement inhibitor C4b-binding protein - PubMed
Review
. 2002 Nov;30(Pt 6):978-82.
doi: 10.1042/bst0300978.
Affiliations
- PMID: 12440957
- DOI: 10.1042/bst0300978
Review
Structural and functional studies of complement inhibitor C4b-binding protein
A M Blom. Biochem Soc Trans. 2002 Nov.
Abstract
C4b-binding protein (C4BP) is a potent inhibitor of the classical pathway of the complement system. This large plasma glycoprotein consists of seven identical alpha-chains and a unique beta-chain held together by disulphide bridges. Both types of subunits are composed almost exclusively of complement control protein domains (CCPs). Using homology-based computer modelling and mutagenesis of recombinant proteins we have localized binding sites for several ligands of C4BP: complement factor C4b, heparin and vitamin K-dependent anticoagulant protein S (PS). We found that C4b requires CCP1-3 of the alpha-chain for binding. The interaction is ionic in nature and mediated by a cluster of positively charged amino acids present on the interface between CCP1 and CCP2 of the alpha-chain. Loss of C4b-binding resulted in a loss of all inhibitory functions of C4BP within the classical pathway of complement. Binding of heparin required CCPs 1-3 of the alpha-chain, with CCP2 being the most important, as well as the cluster of positively charged amino acids involved in binding of C4b. The interaction between C4BP and PS is of very high affinity and conveyed by a cluster of surface exposed hydrophobic amino acids localized on CCP1 of the beta-chain. Furthermore, C4BP is captured on the surface of several pathogens, which may contribute to their serum resistance and pathogenicity. We have localized interaction of C4BP with Neisseria gonorrhoeae, Bordetella pertussis, Streptococcus pyogenes and Escherichia coli to various regions of the alpha-chain.
Similar articles
-
Blom AM, Kask L, Dahlbäck B. Blom AM, et al. Mol Immunol. 2003 Jan;39(10):547-56. doi: 10.1016/s0161-5890(02)00213-4. Mol Immunol. 2003. PMID: 12431388
-
Blom AM, Rytkönen A, Vasquez P, Lindahl G, Dahlbäck B, Jonsson AB. Blom AM, et al. J Immunol. 2001 Jun 1;166(11):6764-70. doi: 10.4049/jimmunol.166.11.6764. J Immunol. 2001. PMID: 11359834
-
Härdig Y, Hillarp A, Dahlbäck B. Härdig Y, et al. Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):469-75. doi: 10.1042/bj3230469. Biochem J. 1997. PMID: 9163340 Free PMC article.
-
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
Blom AM, Villoutreix BO, Dahlbäck B. Blom AM, et al. Mol Immunol. 2004 Apr;40(18):1333-46. doi: 10.1016/j.molimm.2003.12.002. Mol Immunol. 2004. PMID: 15072852 Review.
Cited by
-
Xie HG, Jiang LP, Tai T, Ji JZ, Mi QY. Xie HG, et al. Mol Diagn Ther. 2024 Mar;28(2):189-199. doi: 10.1007/s40291-023-00691-w. Epub 2024 Jan 23. Mol Diagn Ther. 2024. PMID: 38261250 Review.
-
Evolutionary history of orthopoxvirus proteins similar to human complement regulators.
Ciulla E, Emery A, Konz D, Krushkal J. Ciulla E, et al. Gene. 2005 Aug 1;355:40-7. doi: 10.1016/j.gene.2005.05.008. Gene. 2005. PMID: 16023794 Free PMC article.
-
Breda LC, Hsieh CL, Castiblanco Valencia MM, da Silva LB, Barbosa AS, Blom AM, Chang YF, Isaac L. Breda LC, et al. PLoS Negl Trop Dis. 2015 Oct 30;9(10):e0004192. doi: 10.1371/journal.pntd.0004192. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26517116 Free PMC article.
-
Manne K, Chattopadhyay D, Agarwal V, Blom AM, Khare B, Chakravarthy S, Chang C, Ton-That H, Narayana SVL. Manne K, et al. Acta Crystallogr D Struct Biol. 2020 Aug 1;76(Pt 8):759-770. doi: 10.1107/S2059798320008116. Epub 2020 Jul 27. Acta Crystallogr D Struct Biol. 2020. PMID: 32744258 Free PMC article.
-
Protease-dependent mechanisms of complement evasion by bacterial pathogens.
Potempa M, Potempa J. Potempa M, et al. Biol Chem. 2012 Sep;393(9):873-88. doi: 10.1515/hsz-2012-0174. Biol Chem. 2012. PMID: 22944688 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous